Education
About Us
Working with TipRanks
Follow Us
TherapeuticsMD (TXMD)
NASDAQ:TXMD
TXMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.70 - $2.44
Previous CloseN/A
Volume92.69K
Average Volume (3M)18.43K
Market Cap
$12.50M
Enterprise Value$13.96M
Total Cash (Recent Filing)$6.07M
Total Debt (Recent Filing)$5.72M
Price to Earnings (P/E)―
Beta1.63
Next Earnings
Nov 17, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding11,574,362
10 Day Avg. Volume21,969
30 Day Avg. Volume18,432
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)0.36
Price to Sales (P/S)5.63
P/FCF Ratio8.48
Enterprise Value/Market Cap1.12
Enterprise Value/Revenue5.46
Enterprise Value/Gross Profit5.91
Enterprise Value/Ebitda-10.15
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
TherapeuticsMD News
TXMD FAQ
What was TherapeuticsMD’s price range in the past 12 months?
TherapeuticsMD lowest stock price was $0.70 and its highest was $2.44 in the past 12 months.
What is TherapeuticsMD’s market cap?
TherapeuticsMD’s market cap is $12.50M.
When is TherapeuticsMD’s upcoming earnings report date?
TherapeuticsMD’s upcoming earnings report date is Nov 17, 2025 which is in 53 days.
How were TherapeuticsMD’s earnings last quarter?
TherapeuticsMD released its earnings results on Aug 12, 2025. The company reported $0.048 earnings per share for the quarter, beating the consensus estimate of N/A by $0.048.
Is TherapeuticsMD overvalued?
According to Wall Street analysts TherapeuticsMD’s price is currently Overvalued.
Does TherapeuticsMD pay dividends?
TherapeuticsMD does not currently pay dividends.
What is TherapeuticsMD’s EPS estimate?
TherapeuticsMD’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TherapeuticsMD have?
TherapeuticsMD has 11,574,362 shares outstanding.
What happened to TherapeuticsMD’s price movement after its last earnings report?
TherapeuticsMD reported an EPS of $0.048 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5.455%.
Which hedge fund is a major shareholder of TherapeuticsMD?
Currently, no hedge funds are holding shares in TXMD
Company Description
TherapeuticsMD
TherapeuticsMD (TXMD) is a healthcare company focused on developing and commercializing innovative solutions for women's health. The company operates within the pharmaceutical sector, offering a range of products designed to address various stages of women's health, including menopause, pregnancy prevention, and hormone therapy. Their core products include hormone replacement therapies and prenatal vitamins, aimed at improving the overall well-being of women.
Technical Analysis
Prophase Labs
―
Aytu BioScience
―
Kala Pharmaceuticals
―
Cosmos Holdings
―
Biofrontera
―
Ownership Overview
1.48% Insiders
4.46% Mutual Funds
21.07% Other Institutional Investors
70.15% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---